3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase 1
2
Phase NA
1
Phase 3
1
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
19
Leukemia
16
Myelodysplastic Syndromes
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Neuroblastoma
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Monocytic, Acute
3
Leukemia, Megakaryoblastic, Acute
3
Leukemia, Erythroblastic, Acute
3
Congenital Abnormalities
3
Sarcoma, Ewing
2
Neoplasms, Plasma Cell
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Graft vs Host Disease
2
Burkitt Lymphoma
2
Anemia, Refractory, with Excess of Blasts
2
Sarcoma
1
Recurrence
1
Interventions
Paclitaxel
20
Gemcitabine
16
Dexamethasone
16
Bevacizumab
16
Docetaxel
15
Oxaliplatin
14
Cyclophosphamide
13
Carboplatin
12
Capecitabine
12
Sorafenib
11
Fluorouracil
11
Leucovorin
10
Cisplatin
10
pembrolizumab
9
Pemetrexed
9
Epoetin Alfa
9
venetoclax
8
Prednisone
8
Fentanyl
8
Drug Therapy
8
Doxorubicin
8
atezolizumab
7
Rivaroxaban
7
Rituximab
7
Darbepoetin alfa
7
Anastrozole
7
Panitumumab
6
Ondansetron
6
Morphine
6
Irinotecan
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasms
×
Busulfan
×
Clear all
NCT05477589
2024-12-19
SCRIPT-AML
Vastra Gotaland Region
Phase 3
Recruiting
170 enrolled